Pediatric Severe Sepsis and Shock in Three Asian Countries: A Retrospective Study of Outcomes in Nine PICUs
- PMID: 33729727
- DOI: 10.1097/PCC.0000000000002680
Pediatric Severe Sepsis and Shock in Three Asian Countries: A Retrospective Study of Outcomes in Nine PICUs
Abstract
Objectives: Pediatric sepsis remains a major health problem and is a leading cause of death and long-term disability worldwide. This study aims to characterize epidemiologic, therapeutic, and outcome features of pediatric severe sepsis and septic shock in three Asian countries.
Design: A multicenter retrospective study with longitudinal clinical data over 1, 6, 24, 48, and 72 hours of PICU admission. The primary outcome was PICU mortality. Multivariable logistic regression analysis was used to identify factors at PICU admission that were associated with mortality.
Setting: Nine multidisciplinary PICUs in three Asian countries.
Patients: Children with severe sepsis or septic shock admitted to the PICU from January to December 2017.
Intervention: None.
Measurement and main results: A total of 271 children were included in this study. Median (interquartile range) age was 4.2 years (1.3-10.8 yr). Pneumonia (77/271 [28.4%]) was the most common source of infection. Majority of patients (243/271 [90%]) were resuscitated within the first hour, with fluid bolus (199/271 [73.4%]) or vasopressors (162/271 [59.8%]). Fluid resuscitation commonly took the form of normal saline (147/199 [74.2%]) (20 mL/kg [10-20 mL/kg] over 20 min [15-30 min]). The most common inotrope used was norepinephrine 81 of 162 (50.0%). Overall PICU mortality was 52 of 271 (19.2%). Improved hemodynamic variables (e.g., heart rate, blood pressure, and arterial lactate) were seen in survivors within 6 hours of admission as compared to nonsurvivors. In the multivariable model, admission severity score was associated with PICU mortality.
Conclusions: Mortality from pediatric severe sepsis and septic shock remains high in Asia. Consistent with current guidelines, most of the children admitted to these PICUs received fluid therapy and inotropic support as recommended.
Copyright © 2021 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Conflict of interest statement
Dr. Samransamruajkit received funding from the Royal College of Pediatricians of Thailand. Dr. Smathakane disclosed government work. Dr. Phumeetham received funding from Siriraj research development fund. Dr. Jan Hau Lee received funding from KK Women’s and Children’s Hospital. The remaining authors have disclosed that they do not have any potential conflicts of interest
References
-
- Thavamani A, Umapathi KK, Dhanpalreddy H, et al. Epidemiology, clinical and microbiologic profile and risk factors for inpatient mortality in pediatric severe sepsis in the United States From 2003 to 2014: A large population analysis. Pediatr Infect Dis J. 2020; 39:781–788
-
- Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet. 2020; 395:200–211
-
- Weiss SL, Fitzgerald JC, Pappachan J, et al.; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015; 191:1147–1157
-
- de Souza DC, Shieh HH, Barreira ER, et al.; LAPSES Group. Epidemiology of sepsis in children admitted to PICUs in South America. Pediatr Crit Care Med. 2016; 17:727–734
-
- GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390:1151–1210
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
